全文获取类型
| 收费全文 | 18887篇 |
| 免费 | 1712篇 |
| 国内免费 | 49篇 |
专业分类
| 耳鼻咽喉 | 125篇 |
| 儿科学 | 684篇 |
| 妇产科学 | 551篇 |
| 基础医学 | 2715篇 |
| 口腔科学 | 462篇 |
| 临床医学 | 2220篇 |
| 内科学 | 3555篇 |
| 皮肤病学 | 222篇 |
| 神经病学 | 1619篇 |
| 特种医学 | 557篇 |
| 外科学 | 2450篇 |
| 综合类 | 409篇 |
| 一般理论 | 15篇 |
| 预防医学 | 2211篇 |
| 眼科学 | 258篇 |
| 药学 | 1327篇 |
| 中国医学 | 30篇 |
| 肿瘤学 | 1238篇 |
出版年
| 2023年 | 114篇 |
| 2022年 | 112篇 |
| 2021年 | 330篇 |
| 2020年 | 231篇 |
| 2019年 | 376篇 |
| 2018年 | 416篇 |
| 2017年 | 329篇 |
| 2016年 | 334篇 |
| 2015年 | 381篇 |
| 2014年 | 517篇 |
| 2013年 | 719篇 |
| 2012年 | 1090篇 |
| 2011年 | 1111篇 |
| 2010年 | 597篇 |
| 2009年 | 569篇 |
| 2008年 | 938篇 |
| 2007年 | 970篇 |
| 2006年 | 918篇 |
| 2005年 | 865篇 |
| 2004年 | 882篇 |
| 2003年 | 777篇 |
| 2002年 | 729篇 |
| 2001年 | 453篇 |
| 2000年 | 516篇 |
| 1999年 | 475篇 |
| 1998年 | 226篇 |
| 1997年 | 190篇 |
| 1996年 | 190篇 |
| 1995年 | 188篇 |
| 1994年 | 177篇 |
| 1993年 | 160篇 |
| 1992年 | 330篇 |
| 1991年 | 328篇 |
| 1990年 | 353篇 |
| 1989年 | 304篇 |
| 1988年 | 271篇 |
| 1987年 | 260篇 |
| 1986年 | 245篇 |
| 1985年 | 253篇 |
| 1984年 | 186篇 |
| 1983年 | 149篇 |
| 1979年 | 158篇 |
| 1978年 | 131篇 |
| 1977年 | 108篇 |
| 1976年 | 103篇 |
| 1974年 | 130篇 |
| 1973年 | 121篇 |
| 1972年 | 118篇 |
| 1971年 | 118篇 |
| 1970年 | 107篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献8.
9.
Béla Nagy Zsolt Bene Zsolt Fejes Sonya L. Heltshe David Reid Nicola J. Ronan Yvonne McCarthy Daniel Smith Attila Nagy Elizabeth Joseloff György Balla János Kappelmayer Milan Macek Scott C. Bell Barry J. Plant Margarida D. Amaral István Balogh 《Journal of cystic fibrosis》2019,18(2):271-277
Background
We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.Methods
In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).Results
After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).Conclusions
This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy. 相似文献10.
Sebel Luke E. B.S.; Richardson James E. M.D.&#x;; Singh Sunil P. B.S.&#x;; Bell Shannon V. B.S.
; Jenkins Andrew Ph.D.# 《Anesthesiology》2006,104(6):1176-1183
Background: Previous studies have shown that propofol and sevoflurane enhance the function of [gamma]-aminobutyric acid type A (GABAA) receptors. However, it is not known whether these two drugs modulate the same molecular pathways. In addition, little is known about receptor function in the presence of both propofol and sevoflurane. The aim of this study was to better understand the interactions of propofol and sevoflurane with the GABAA receptor.
Methods: Wild-type [alpha]1, [beta]2, [gamma]2s GABAA receptor subunit complementary DNAs were transfected into human embryonic kidney cells grown on glass coverslips using a calcium phosphate transfection method. After transfection (36-72 h), cells were whole cell patch clamped and exposed to combinations of the following: 0.3-1,000 [mu]m [gamma]-aminobutyric acid (GABA), 0-10 [mu]m propofol, and 0-1,650 [mu]m sevoflurane. Chemicals were delivered to the cells using two 10-channel infusion pumps and a rapid solution exchanger.
Results: Both propofol and sevoflurane alone enhanced the amplitude of GABAA receptor responses to submaximal concentrations of GABA in a dose-dependent manner. The enhancement was underpinned by an increase in the apparent affinity of the receptor for GABA. Coapplication of both anesthetics further enhanced the apparent affinity of the receptor for GABA. 相似文献